Albrecht F E, Drago J, Felder R A, Printz M P, Eisner G M, Robillard J E, Sibley D R, Westphal H J, Jose P A
Georgetown University Medical Center, Department of Pediatrics, Washington, DC 20007, USA.
J Clin Invest. 1996 May 15;97(10):2283-8. doi: 10.1172/JCI118670.
Since dopamine produced by the kidney is an intrarenal regulator of sodium transport, an abnormality of the dopaminergic system may be important in the pathogenesis of hypertension. In the spontaneously hypertensive rat (SHR), in spite of normal renal production of dopamine and receptor density, there is defective transduction of the D1 receptor signal in renal proximal tubules, resulting in decreased inhibition of sodium transport (Na+/H+ exchanger [NHE] and Na+/K+ATPase activity) by dopamine. To determine if impaired D1 receptor regulation of NHE in proximal tubules is related to hypertension, studies were performed in a F2 generation from female Wistar Kyoto (WKY) and male SHR crosses. A D1 agonist, SKF 81297, inhibited (37.6 +/- 4.7%) NHE activity in brush border membranes of normotensive F2s (systolic blood pressure < 140 mm Hg, n = 7) but not in hypertensive F2s (n = 21). Furthermore, a D1 agonist, SKF 38393, when infused into the renal artery, dose dependently increased sodium excretion in normotensive F2s (n = 3) without altering renal blood flow but was inactive in hypertensive F2s (n = 21). Since the major D1 receptor gene expressed in renal proximal tubules is the D1A subtype, we determined the importance of this gene in the control of blood pressure in mice lacking functional D1A receptors. Systolic blood pressure was greater in homozygous (n = 6) and heterozygous (n = 5) mice compared to normal sex matched litter mate controls (n = 12); moreover, the mice lacking one or both D1A alleles developed diastolic hypertension. The cosegregation with hypertension of an impaired D1 receptor regulation of renal sodium transport and the development of elevated systolic and diastolic pressure in mice lacking one or both D1A alleles suggest a causal relationship of the D1A receptor gene with hypertension.
由于肾脏产生的多巴胺是钠转运的肾内调节因子,多巴胺能系统异常可能在高血压发病机制中起重要作用。在自发性高血压大鼠(SHR)中,尽管肾脏多巴胺生成和受体密度正常,但肾近端小管中D1受体信号转导存在缺陷,导致多巴胺对钠转运(钠/氢交换体[NHE]和钠/钾ATP酶活性)的抑制作用减弱。为了确定近端小管中NHE的D1受体调节受损是否与高血压有关,我们对雌性Wistar Kyoto(WKY)和雄性SHR杂交的F2代进行了研究。D1激动剂SKF 81297可抑制血压正常的F2代(收缩压<140 mmHg,n = 7)刷状缘膜中的NHE活性,但对高血压F2代(n = 21)无效。此外,D1激动剂SKF 38393经肾动脉注入时,可使血压正常的F2代(n = 3)钠排泄量呈剂量依赖性增加,且不改变肾血流量,但对高血压F2代(n = 21)无作用。由于肾近端小管中表达的主要D1受体基因是D1A亚型,我们确定了该基因在缺乏功能性D1A受体的小鼠血压控制中的重要性。与正常性别匹配的同窝对照小鼠(n = 12)相比,纯合子(n = 6)和杂合子(n = 5)小鼠的收缩压更高;此外,缺乏一个或两个D1A等位基因的小鼠出现舒张期高血压。肾钠转运的D1受体调节受损与高血压的共分离以及缺乏一个或两个D1A等位基因的小鼠收缩压和舒张压升高表明D1A受体基因与高血压之间存在因果关系。